Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

28 Aug 2007 15:35

Concurrent Technologies Plc Product Launch New VME dual-core processor, dual PMC board

Concurrent Technologies Plc ("Concurrent") a world leading specialist in the design and manufacture of high-end embedded computer products, announces the launch of its latest single-slot VME dual PMC single board computer, the VP 417 /03x. It uses the latest mobile dual-core processors from Intel‚®, giving customers improved performance/watt and making it ideal for low power intensive processing applications.

This new board represents an upgrade from the previous VP 31x/02x family and so will be of great interest to Concurrent's existing customer base looking for increased performance with new and next generation projects. The VP 417/03x includes extensive input/output functionality and flexibility and is currently available in commercial and extended temperature versions; the ruggedised, conduction-cooled versions will be introduced shortly. All of these features will make the board suitable for a range of applications within the defence, industrial control and transportation markets. Developing products that provide increased performance well suited to customers' demanding applications is key to the Company's current marketing drive.

Glen Fawcett, Managing Director, commented:

"The release of this new VME family of single board computers is part of our continuing product development plans to provide an upgrade path for our main Pentium M based boards to the very latest Intel‚® dual-core processors.

"This high performance VME product is pin compatible with the earlier generation product and therefore provides an easy technology upgrade for existing customers. It will also be available later this year in a ruggedised format and should therefore also be an attractive solution for applications within very harsh environments."

28 August 2007Contacts:Concurrent Technologies Plc 01206 752 626 Glen Fawcett, Managing Director Nexus Financial Ltd 020 7451 7050 Nicholas Nelson/Kathy Boate Nominated Adviser Brewin Dolphin Investment Banking Alan Stewart 0845 213 1120

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

Notes to Editors:

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using the latest Intel‚® Core¢â€ž¢ dual core processors, the single board computers support high performance applications, some being capable of operating in temperatures from -40‚ºC to +85 ‚ºC for applications within harsher environments. Concurrent produces a wide range of boards designed according to industry standard specifications including CompactPCI‚®, VME boards, AdvancedMC¢â€ž¢, PCI Mezzanine Cards and Multibus II.

The VP 417/03x has two 66MHz PMC sites and extensive I/O functionality and can support VITA 31.1. The board also supports the 2.16 Ghz Intel‚® Core¢â€ž¢ 2 Duo T7400 processor or 1.5 GHz Intel‚® Core¢â€ž¢ 2 Duo L7400 processor, each with 4 Mbytes L2 cache and both supporting 64-bit operating systems. The VP 417/03x supports many of today's leading operating systems, including Linux‚®, Windows‚® XP Embedded, Windows‚® XP, Windows‚® 2000, Solaris¢â€ž¢, LynxOS‚®, QNX‚® and VxWorks‚®.

CONCURRENT TECHNOLOGIES PLC
Date   Source Headline
22nd May 20183:41 pmRNSAGM Statement
21st May 20187:00 amRNSProduct Announcement
30th Apr 20189:30 amRNSDistribution of Annual Report and Accounts
4th Apr 20187:00 amRNSResults for the year ended 31 December 2017
3rd Apr 20189:01 amRNSProduct Announcement
28th Mar 20184:03 pmRNSNotice of Results
27th Mar 20182:14 pmRNSProduct Announcement
8th Mar 20187:00 amRNSSecond Interim Dividend
26th Feb 201810:17 amRNSCorrection - Product Announcement
26th Feb 20187:00 amRNSProduct Announcement
21st Feb 20187:00 amRNSProduct Announcement
23rd Jan 20187:00 amRNSProduct Announcement
21st Dec 20177:00 amRNSPre-Close Trading Update
30th Nov 20171:29 pmRNSProduct Announcement
18th Sep 20177:00 amRNSInterim Results for the six months ended 30 Jun 17
5th Sep 20177:00 amRNSNotice of Results
26th Jun 20177:00 amRNSProduct Announcement
25th May 20172:57 pmRNSResult of AGM
9th May 20177:00 amRNSNotice of AGM
12th Apr 20172:08 pmRNSDistribution of Annual Report and Accounts
30th Mar 201711:18 amRNSHolding(s) in Company
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding
18th Apr 20162:14 pmRNSDirector/PDMR Shareholding
18th Apr 201610:55 amRNSPosting of Annual Report & Accounts
29th Mar 20164:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.